Porton Pharma Solutions
Provides CDMO services for small-molecule APIs and drug products, cell and gene therapies, peptides, oligonucleotides, and conjugates.
Corporate information
- Company entity
- 重庆博腾制药科技股份有限公司
- Headquarters / principal office
- Chongqing, China (small molecules); Shanghai, China (TIDES / biologics operations)Corporate website explicitly identifies headquarters; location follows the retrieved disclosure. ↗
- Founded
- 2005 ↗
- Ownership / capital status
- Publicly tradedPublicly traded (SZSE 300363) ↗
- Official corporate reference
- https://www.portonpharma.com/ ↗
- LinkedIn company page
- LinkedIn ↗ ↗
Profile review: 2026-11-04 · Fields retain their individual source dates. Undisclosed values are not zero; early or historical events do not establish the latest financing. Awards and acquisitions are distinguished from equity rounds.
Public evidence snapshot
Provides CDMO services for small-molecule APIs and drug products, cell and gene therapies, peptides, oligonucleotides, and conjugates.
This profile is a research snapshot, not a company endorsement. Check original sources for current information.